Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Revenues	$ 0	$ 0
OPERATING EXPENSES:
General and administrative expenses	219,656	23,595
Payroll and compensation	2,056,144	0
Research and development	91,301	33,385
Debt transaction expenses	110,685	0
Amortization of patents	60,839	51,028
Total operating expenses	2,538,625	108,008
OPERATING LOSS	(2,538,625)	(108,008)
OTHER INCOME (EXPENSE):
Interest expense	(531,796)	(32,295)
Gain on convertible notes	206,474	0
Loss on change in fair market values of derivative liabilities	(159,324)	0
Loss on merger	(294,788)	0
TOTAL OTHER EXPENSES	(779,434)	(32,295)
NET LOSS	(3,318,059)	(140,303)
Net Loss attributable to noncontrolling interests in variable interest entity and subsidiary	0	12,439
Net loss attributable to Company stockholders	$ (3,318,059)	$ (127,864)
LOSS PER SHARE:
Basic and Diluted	$ (0.04)	$ (1,278.64)
WEIGHTED AVERAGE SHARES OUTSTANDING:
Basic and Diluted	89,680,567	100